Results 41 to 50 of about 1,327,504 (271)

Artificial Intelligence‐Guided Phenotypic Drug Repurposing Against Streptococcus pneumoniae

open access: yesAdvanced Science, EarlyView.
Integrated artificial intelligence (AI) ensembles identify highly potent repurposed drugs against Streptococcus pneumoniae. Prospective virtual screening of 6747 drugs uncovers nine active candidates, including thiostrepton. This drug exhibits low picomolar potency and bypasses established resistance in multidrug‐resistant strains, demonstrating an ...
Joshua S. Fitch   +6 more
wiley   +1 more source

Beta lactam antibiotics residues in cow's milk: comparison of efficacy of three screening tests used in Bosnia and Herzegovina

open access: yesBiomolecules & Biomedicine, 2014
Beta lactam antibiotics are widely used in therapy of cattle, particularly for the treatment of mastitis.  Over 95% of residue testing in dairies in Bosnia and Herzegovina is for Beta lactams.
Nihad Fejzic   +3 more
doaj   +1 more source

EFFECTS OF INDUCIBLE BETA-LACTAMASE AND ANTIMICROBIAL RESISTANCE UPON THE ACTIVITY OF NEWER BETA-LACTAM ANTIBIOTICS AGAINST PSEUDOMONAS AERUGINOSA

open access: yes, 1981
The activity of carbenicillin, ticarcillin, piperacillin, cefotaxime, moxalactam, and N-formimidoyl thienamycin was evaluated against 262 clinical isolates of Pseudoanams aeruginosa.
BERCUSON, DON H   +2 more
core   +1 more source

Structural Basis of Shiga Toxin Neutralization by Human Antibodies Targeting Canonical Receptor‐Binding and Non‐Canonical Assembly Sites

open access: yesAdvanced Science, EarlyView.
Cryo‐electron microscopy structures reveal two distinct neutralization mechanisms of fully human monoclonal antibodies targeting the Shiga toxin 1a B subunit. RDS059 occludes the Gb3 receptor‐binding site, whereas RDS045 engages a lateral quaternary epitope to disrupt holotoxin assembly.
Jianting Ke   +10 more
wiley   +1 more source

The Importance of Porins and β-Lactamase in Outer Membrane Vesicles on the Hydrolysis of β-Lactam Antibiotics

open access: yes, 2020
Gram-negative bacteria have an outer membrane inhibiting the entry of antibiotics. Porins, found within the outer membrane, are involved in regulating the permeability of β-lactam antibiotics.
Jong-Su Seo   +31 more
core   +1 more source

Predicting Enzyme Turnover Numbers and Enabling Rational Enzyme Evolution

open access: yesAdvanced Science, EarlyView.
MCKcat, a deep learning framework combining multi‐scale convolution and cross‐attention, accurately predicts enzyme turnover number (kcat) by fusing sequence and reaction representations. It couples with rational design in a two‐step strategy for Bacillus aryabhattai laccase engineering, achieving a 75% positive rate with synergistically enhanced ...
Fengya Ge   +6 more
wiley   +1 more source

Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
IntroductionNovel last resort beta-lactam antibiotics are now available for management of infections due to New-Delhi Metallo-Beta-Lactamase (NDM) producing Enterobacterales and non-fermenters with Difficult-to-Treat Resistance.
Romaric Larcher   +14 more
doaj   +1 more source

Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus Dosing

open access: yes, 2009
Background: In vitro studies suggest that administering betalactam antibiotics by continuous infusion may maximise efficacy. Several pharmacokinetic studies have compared the distribution of beta-lactam antibiotics administered by continuous and bolus ...
Jason A Roberts   +3 more
core   +1 more source

Defeating Multidrug‐Resistant ESKAPEE Pathogens With Polymer Nanomaterials

open access: yesAdvanced Science, EarlyView.
Antimicrobial resistance, particularly among ESKAPEE pathogens, represents a major global health threat and drives the need for innovative treatments. Polymer‐based strategies offer promising alternatives to conventional antibiotics by overcoming resistance mechanisms.
Thu Ba Tô   +4 more
wiley   +1 more source

Multi-screening of beta-lactam antibiotics for beta-lactamase resistance by means of a paper-based analytical device with a 4-(2-pyridylazo)resorcinol (PAR)-Hg2+ complex

open access: yes, 2019
beta-Lactam antibiotics are widely used for the treatment of bacterial infections; however, an increase in the number of antibiotic-resistant bacteria, which produce beta-lactamases that inactivate beta-lactam antibiotics, can lead to serious untreatable
Han, Min Su   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy